Dietary sodium restriction decreases insulin secretion without affecting insulin sensitivity in humans

James M Luther1, Loretta M Byrne, Chang Yu

  • 1Divisions of Clinical Pharmacology, Department of Medicine (J.M.L., L.M.B., N.J.B.), Nephrology and Hypertension (J.M.L.), and Cardiovascular Medicine (T.J.W.), and Departments of Biostatistics (C.Y.) and Pharmacology (J.M.L.), Vanderbilt University Medical Center, Nashville, Tennessee 37232-6602.

Abstract

Insights

Low dietary sodium intake significantly reduces insulin and C-peptide secretion in humans. This effect occurs independently of changes in insulin sensitivity, highlighting a novel mechanism impacting glucose metabolism.

Area of Science:

  • Endocrinology
  • Metabolic Research
  • Human Physiology

Background:

  • The renin-angiotensin-aldosterone system (RAAS) plays a role in preventing diabetes in high-risk individuals, but the precise mechanism is not fully understood.
  • Investigating the impact of RAAS activation on insulin secretion is crucial for understanding glucose homeostasis and diabetes development.

Purpose of the Study:

  • To test the hypothesis that activation of the endogenous RAAS or exogenous aldosterone impairs insulin secretion in humans.
  • To elucidate the role of dietary sodium intake in modulating insulin secretion and sensitivity.

Main Methods:

  • A randomized, blinded crossover study design was employed, comparing aldosterone infusion versus vehicle control.
  • Participants underwent dietary interventions with either low-sodium (20 mmol/d) or high-sodium (160 mmol/d) intake for 5-7 days.
  • Acute insulin secretory response was assessed using hyperglycemic clamps under controlled sodium balance.

Main Results:

  • A low-sodium diet led to increased endogenous aldosterone and plasma renin activity.
  • The acute glucose-stimulated insulin response decreased by 16.0% (P = .007) and C-peptide response by 21.8% (P = .014) during low sodium intake.
  • Exogenous aldosterone infusion did not significantly alter acute insulin response or insulin sensitivity index.

Conclusions:

  • Low dietary sodium intake demonstrably reduces insulin secretion in humans.
  • This reduction in insulin secretion is independent of changes in insulin sensitivity.
  • Findings suggest a direct effect of sodium balance on pancreatic beta-cell function.

Related Concept Videos

Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
2.7K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.3K
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
2.6K
Regulation of Sodium and Potassium01:26

Regulation of Sodium and Potassium

The regulation of sodium and potassium ion concentrations in the human body is a complex process governed primarily by hormones such as aldosterone, antidiuretic hormone (ADH), and atrial natriuretic peptide (ANP).
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily...
2.8K
Diabetes Insipidus I: Introduction01:29

Diabetes Insipidus I: Introduction

Definition Diabetes insipidus is a disorder marked by the production of large amounts of dilute urine because of impaired vasopressin production, release, or kidney response. The lack of effective vasopressin action limits water reabsorption in the renal collecting ducts, which leads to excessive urinary water loss and intense thirst.Clinical PresentationIndividuals with diabetes insipidus report persistent thirst and very high urine output. In severe cases, fluid intake can reach up to 20...
40
Diabetes Insipidus II: Pathophysiology01:22

Diabetes Insipidus II: Pathophysiology

Normally, water balance is maintained through three interconnected mechanisms: the hypothalamic thirst center, the synthesis and release of antidiuretic hormone (ADH, or vasopressin), and the kidneys' responsiveness to this hormone. ADH is synthesized in the hypothalamus, released from the posterior pituitary, and acts on the distal nephron, allowing water reabsorption and concentrated urine production.Diabetes Insipidus and Its TypesIn diabetes insipidus (DI), this regulatory system is...
21